unknown
Stage
About
Calimmune is a clinical-stage biotechnology company developing gene-modified cell therapies for the treatment and potential cure of HIV/AIDS and other immune-related diseases.
Explore Calimmune's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.